Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up

Journal of Clinical Oncology

Volumn 22, Issue 15, 2004, Pages 3016-3022

  Fernández Martos, Carlos ^a   Aparicio, Jorge ^a   Bosch, Carles ^a   Torregrosa, Marilo ^a   Campos, Juan Manuel ^a   Garcera, Salvador ^a   Vicent, Jose Maria ^a   Maestu, Inmaculada ^a   Climent, Miguel Angel ^a   Mengual, Jose Luis ^a   Tormo, Alejandro ^a   Hernandez, Ana ^a   Estevan, Rafael ^a   Richart, Jose Maria ^a   Viciano, Vicente ^a   Uribe, Natalia ^a   Campos, Jorge ^a   Puchades, Ramon ^a   Arlandis, Francisco ^a   Almenar, Daniel ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; UFT; 1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; TEGAFUR; URACIL;

ANUS SPHINCTER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL VIABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM CANCER; SAFETY; THROMBOCYTOPENIA; ADENOCARCINOMA; ADULT; AGED; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RECTUM TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RECTAL NEOPLASMS; TEGAFUR; URACIL;

EID: 4143132330     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.11.124     Document Type: Article

References (30)

1. Byfield JE, Calabro-Jones P, Klisak I, et al: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 8:1923-1933, 1982
2. Smalley SR, Kimler BF, Evans RG: 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 20:207-211, 1991
3. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
4. Smalley SR, Benedetti J, Williamson S, et al: Intergroup 0144 - phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer: Bolus 5-FU vs prolonged venous infusion (PVI) before and after XRT + PVI vs bolus 5-FU + leucovorin (LV) + levamisole (LEV) before and after XRT + bolus 5-FU + LV. Proc Am Soc Clin Oncol 22:251, 2003 (abstr 1006)
5. Rich TA, Skibber JM, Ajani JA, et al: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32:1025-1029, 1995
6. Mehta VK, Poen J, Ford J, et al: Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 44:52-58, 2001
7. Bosset JF, Magnin V, Maingon P, et al: Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 46:323-327, 2000
8. Grann A, Feng C, Wong D, et al: Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49:987-995, 2001
9. Hyams DM, Mamounas EP, Petrelli N, et al: A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum 40:131-139, 1997
10. Ho DH, Pazdur R, Covington W, et al: Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 4:2085-2088, 1998
11. Douillard JY, Hoff PM, Skillings JR, et al: Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3605-3616, 2002
12. Carmichael J, Popiela T, Radstone D, et al: Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3617-3627, 2002
13. Hoff PM, Janjan N, Saad ED, et al: Phase I study of pre-operative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 18:3529-3534, 2000
14. Tepper JE, O'Connell M, Niedzwiecki D, et al: Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - Final report of Intergroup 0114. J Clin Oncol 20:1744-1750, 2002
15. Fernandez-Martos C, Aparicio J, Bosch C, et al: Pre-operative therapy (PT) with oral uracil and tegafur (UFT) and concomitant irradiation (RT) in operable rectal cancer (RC): Preliminary results of a multicenter phase II study. Proc Am Soc Clin Oncol 20:148a, 2001 (abstr 590)
16. Sobin LH, Wittekind Ch: UICC: TNM Classification of Malignant Tumors (ed 5). New York, NY, Wiley-Liss, 1997
17. Meterissian S, Skibber J, Rich T, et al: Patterns of residual disease after pre-operative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol 1:111-116, 1994
18. Minsky B: UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: A comprehensive review. Int J Cancer 96:1-10, 2001
19. Pazdur R, Lassere Y, Diaz-Canton E, et al: Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: Demonstration of schedule-dependent toxicities. Anticancer Drugs 7:728-733, 1996
20. Minsky BD: Primary treatment of rectal cancer: Present and future. Crit Rev Oncol Hematol 32:19-30, 1999
21. de la Torre A, Ramos S, Valcarcel FJ, et al: Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 45:629-634, 1999
22. Feliu J, Calvilio J, Escribano A, et al: Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 13:730-736, 2002
23. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Pre-operative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
24. Tepper JE, O'Connell MJ, Petroni GR, et al: Adjuvant post-operative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114. J Clin Oncol 15:2030-2039, 1997
25. Janjan NA, Abbruzzese J, Pazdur R, et al: Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 51:153-160, 1999
26. Valentini V, Coco C, Picciocchi A, et al: Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664-674, 2002
27. Crane CH, Skibber JM, Feig BW, et al: Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97:517-524, 2003
28. Fernandez-Martos C, Aparicio, J, Bosch C, et al: Combined modality treatment with oxaliplatin, oral uracil and tegafur (UFT) and concomitant irradiation (RT) in rectal cancer: A dose-finding study. Proc Am Soc Clin Oncol 22:322, 2003 (abstr 1293)
29. Rodel C, Grabenbauer GG, Papadopoulos T, et al: Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098-3104, 2003
30. Mehta VK, Cho C, Ford JM, et al: Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55:132-137, 2003